Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si

Considering the emerging advantages related to da Vinci Xi robotic platform, the aim of this study is to compare for the first time the operative outcomes of this tool to the previous da Vinci Si during transoral robotic surgery (TORS), both performed for squamous cell carcinomas (SCC) of the base o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of robotic surgery 2018-09, Vol.12 (3), p.417-423
Hauptverfasser: Alessandrini, Marco, Pavone, Isabella, Micarelli, Alessandro, Caporale, Claudio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 423
container_issue 3
container_start_page 417
container_title Journal of robotic surgery
container_volume 12
creator Alessandrini, Marco
Pavone, Isabella
Micarelli, Alessandro
Caporale, Claudio
description Considering the emerging advantages related to da Vinci Xi robotic platform, the aim of this study is to compare for the first time the operative outcomes of this tool to the previous da Vinci Si during transoral robotic surgery (TORS), both performed for squamous cell carcinomas (SCC) of the base of tongue (BOT). Intra- and peri-operative outcomes of eight patients with early stage (T1–T2) of the BOT carcinoma and undergoing TORS by means of the da Vinci Xi robotic platform (Xi-TORS) are compared with the da Vinci Si group ones (Si-TORS). With respect to Si-TORS group, Xi-TORS group demonstrated a significantly shorter overall operative time, console time, and intraoperative blood loss, as well as peri-operative pain intensity and length of mean hospital stays and nasogastric tube positioning. Considering recent advantages offered by surgical robotic techniques, the da Vinci Xi Surgical System preliminary outcomes could suggest its possible future routine implementation in BOT squamous cell carcinoma procedures.
doi_str_mv 10.1007/s11701-017-0750-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1938854089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1938854089</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-cccb8e797d7a6db6fbd5a1e6b0f3269b02aa0dc83bd76120ee4877638f62bd3b3</originalsourceid><addsrcrecordid>eNp1kUuLFTEQRoMozjj6A9xIgRs3rXnc7qTdyeALBlw4irtQSarHDN3JnaQbceF_N5c7jiC4SkFOfVXFYeyp4C8F5_pVFUJz0XGhO6573o332Kkwg-rkbhT372qjTtijWq8573WvxEN2Is3Ie2n0Kft1WTDVXHCGkl1eo4e6lSsqP2HKBdbvBA4rQZ5gzelqI6g3Gy55q-BpnsFj8THlBV8Dwr7QHJeYsHX7vOyxxJoTOFp_ECUICF9j8hG-RcAU4HN8zB5MOFd6cvuesS_v3l6ef-guPr3_eP7movNKy7Xz3jtDetRB4xDcMLnQo6DB8UnJYXRcIvLgjXJBD0Jyop3RelBmGqQLyqkz9uKYuy_5ZqO62iXWw_6YqJ1ixaiM6XfcjA19_g96nbeS2nZWjsJo0WttGiWOlC-51kKT3Ze4tLut4Pbgxh7d2ObGHtzYQ_Kz2-TNLRTuOv7IaIA8ArV9pebg7-j_p_4G33GbHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918715778</pqid></control><display><type>article</type><title>Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Alessandrini, Marco ; Pavone, Isabella ; Micarelli, Alessandro ; Caporale, Claudio</creator><creatorcontrib>Alessandrini, Marco ; Pavone, Isabella ; Micarelli, Alessandro ; Caporale, Claudio</creatorcontrib><description>Considering the emerging advantages related to da Vinci Xi robotic platform, the aim of this study is to compare for the first time the operative outcomes of this tool to the previous da Vinci Si during transoral robotic surgery (TORS), both performed for squamous cell carcinomas (SCC) of the base of tongue (BOT). Intra- and peri-operative outcomes of eight patients with early stage (T1–T2) of the BOT carcinoma and undergoing TORS by means of the da Vinci Xi robotic platform (Xi-TORS) are compared with the da Vinci Si group ones (Si-TORS). With respect to Si-TORS group, Xi-TORS group demonstrated a significantly shorter overall operative time, console time, and intraoperative blood loss, as well as peri-operative pain intensity and length of mean hospital stays and nasogastric tube positioning. Considering recent advantages offered by surgical robotic techniques, the da Vinci Xi Surgical System preliminary outcomes could suggest its possible future routine implementation in BOT squamous cell carcinoma procedures.</description><identifier>ISSN: 1863-2483</identifier><identifier>EISSN: 1863-2491</identifier><identifier>DOI: 10.1007/s11701-017-0750-9</identifier><identifier>PMID: 28905287</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Aged ; Aged, 80 and over ; Cancer ; Carcinoma, Squamous Cell - surgery ; FDA approval ; Female ; General anesthesia ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Minimally Invasive Surgery ; Original Article ; Ostomy ; Patients ; Robotic surgery ; Robotic Surgical Procedures - methods ; Robotic Surgical Procedures - statistics &amp; numerical data ; Squamous cell carcinoma ; Surgeons ; Surgery ; Surgical outcomes ; Tongue ; Tongue Neoplasms - surgery ; Treatment Outcome ; Tumors ; Urology ; Variance analysis</subject><ispartof>Journal of robotic surgery, 2018-09, Vol.12 (3), p.417-423</ispartof><rights>Springer-Verlag London Ltd. 2017</rights><rights>Springer-Verlag London Ltd. 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-cccb8e797d7a6db6fbd5a1e6b0f3269b02aa0dc83bd76120ee4877638f62bd3b3</citedby><cites>FETCH-LOGICAL-c372t-cccb8e797d7a6db6fbd5a1e6b0f3269b02aa0dc83bd76120ee4877638f62bd3b3</cites><orcidid>0000-0002-1535-6312</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11701-017-0750-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918715778?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21367,27901,27902,33721,33722,41464,42533,43781,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28905287$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alessandrini, Marco</creatorcontrib><creatorcontrib>Pavone, Isabella</creatorcontrib><creatorcontrib>Micarelli, Alessandro</creatorcontrib><creatorcontrib>Caporale, Claudio</creatorcontrib><title>Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si</title><title>Journal of robotic surgery</title><addtitle>J Robotic Surg</addtitle><addtitle>J Robot Surg</addtitle><description>Considering the emerging advantages related to da Vinci Xi robotic platform, the aim of this study is to compare for the first time the operative outcomes of this tool to the previous da Vinci Si during transoral robotic surgery (TORS), both performed for squamous cell carcinomas (SCC) of the base of tongue (BOT). Intra- and peri-operative outcomes of eight patients with early stage (T1–T2) of the BOT carcinoma and undergoing TORS by means of the da Vinci Xi robotic platform (Xi-TORS) are compared with the da Vinci Si group ones (Si-TORS). With respect to Si-TORS group, Xi-TORS group demonstrated a significantly shorter overall operative time, console time, and intraoperative blood loss, as well as peri-operative pain intensity and length of mean hospital stays and nasogastric tube positioning. Considering recent advantages offered by surgical robotic techniques, the da Vinci Xi Surgical System preliminary outcomes could suggest its possible future routine implementation in BOT squamous cell carcinoma procedures.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>FDA approval</subject><subject>Female</subject><subject>General anesthesia</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgery</subject><subject>Original Article</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Robotic surgery</subject><subject>Robotic Surgical Procedures - methods</subject><subject>Robotic Surgical Procedures - statistics &amp; numerical data</subject><subject>Squamous cell carcinoma</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Tongue</subject><subject>Tongue Neoplasms - surgery</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Urology</subject><subject>Variance analysis</subject><issn>1863-2483</issn><issn>1863-2491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kUuLFTEQRoMozjj6A9xIgRs3rXnc7qTdyeALBlw4irtQSarHDN3JnaQbceF_N5c7jiC4SkFOfVXFYeyp4C8F5_pVFUJz0XGhO6573o332Kkwg-rkbhT372qjTtijWq8573WvxEN2Is3Ie2n0Kft1WTDVXHCGkl1eo4e6lSsqP2HKBdbvBA4rQZ5gzelqI6g3Gy55q-BpnsFj8THlBV8Dwr7QHJeYsHX7vOyxxJoTOFp_ECUICF9j8hG-RcAU4HN8zB5MOFd6cvuesS_v3l6ef-guPr3_eP7movNKy7Xz3jtDetRB4xDcMLnQo6DB8UnJYXRcIvLgjXJBD0Jyop3RelBmGqQLyqkz9uKYuy_5ZqO62iXWw_6YqJ1ixaiM6XfcjA19_g96nbeS2nZWjsJo0WttGiWOlC-51kKT3Ze4tLut4Pbgxh7d2ObGHtzYQ_Kz2-TNLRTuOv7IaIA8ArV9pebg7-j_p_4G33GbHQ</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Alessandrini, Marco</creator><creator>Pavone, Isabella</creator><creator>Micarelli, Alessandro</creator><creator>Caporale, Claudio</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M7S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1535-6312</orcidid></search><sort><creationdate>20180901</creationdate><title>Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si</title><author>Alessandrini, Marco ; Pavone, Isabella ; Micarelli, Alessandro ; Caporale, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-cccb8e797d7a6db6fbd5a1e6b0f3269b02aa0dc83bd76120ee4877638f62bd3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>FDA approval</topic><topic>Female</topic><topic>General anesthesia</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgery</topic><topic>Original Article</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Robotic surgery</topic><topic>Robotic Surgical Procedures - methods</topic><topic>Robotic Surgical Procedures - statistics &amp; numerical data</topic><topic>Squamous cell carcinoma</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Tongue</topic><topic>Tongue Neoplasms - surgery</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Urology</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alessandrini, Marco</creatorcontrib><creatorcontrib>Pavone, Isabella</creatorcontrib><creatorcontrib>Micarelli, Alessandro</creatorcontrib><creatorcontrib>Caporale, Claudio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Engineering Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of robotic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alessandrini, Marco</au><au>Pavone, Isabella</au><au>Micarelli, Alessandro</au><au>Caporale, Claudio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si</atitle><jtitle>Journal of robotic surgery</jtitle><stitle>J Robotic Surg</stitle><addtitle>J Robot Surg</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>12</volume><issue>3</issue><spage>417</spage><epage>423</epage><pages>417-423</pages><issn>1863-2483</issn><eissn>1863-2491</eissn><abstract>Considering the emerging advantages related to da Vinci Xi robotic platform, the aim of this study is to compare for the first time the operative outcomes of this tool to the previous da Vinci Si during transoral robotic surgery (TORS), both performed for squamous cell carcinomas (SCC) of the base of tongue (BOT). Intra- and peri-operative outcomes of eight patients with early stage (T1–T2) of the BOT carcinoma and undergoing TORS by means of the da Vinci Xi robotic platform (Xi-TORS) are compared with the da Vinci Si group ones (Si-TORS). With respect to Si-TORS group, Xi-TORS group demonstrated a significantly shorter overall operative time, console time, and intraoperative blood loss, as well as peri-operative pain intensity and length of mean hospital stays and nasogastric tube positioning. Considering recent advantages offered by surgical robotic techniques, the da Vinci Xi Surgical System preliminary outcomes could suggest its possible future routine implementation in BOT squamous cell carcinoma procedures.</abstract><cop>London</cop><pub>Springer London</pub><pmid>28905287</pmid><doi>10.1007/s11701-017-0750-9</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1535-6312</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1863-2483
ispartof Journal of robotic surgery, 2018-09, Vol.12 (3), p.417-423
issn 1863-2483
1863-2491
language eng
recordid cdi_proquest_miscellaneous_1938854089
source MEDLINE; SpringerLink Journals - AutoHoldings; ProQuest Central
subjects Aged
Aged, 80 and over
Cancer
Carcinoma, Squamous Cell - surgery
FDA approval
Female
General anesthesia
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Minimally Invasive Surgery
Original Article
Ostomy
Patients
Robotic surgery
Robotic Surgical Procedures - methods
Robotic Surgical Procedures - statistics & numerical data
Squamous cell carcinoma
Surgeons
Surgery
Surgical outcomes
Tongue
Tongue Neoplasms - surgery
Treatment Outcome
Tumors
Urology
Variance analysis
title Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transoral%20robotic%20surgery%20for%20the%20base%20of%20tongue%20squamous%20cell%20carcinoma:%20a%20preliminary%20comparison%20between%20da%20Vinci%20Xi%20and%20Si&rft.jtitle=Journal%20of%20robotic%20surgery&rft.au=Alessandrini,%20Marco&rft.date=2018-09-01&rft.volume=12&rft.issue=3&rft.spage=417&rft.epage=423&rft.pages=417-423&rft.issn=1863-2483&rft.eissn=1863-2491&rft_id=info:doi/10.1007/s11701-017-0750-9&rft_dat=%3Cproquest_cross%3E1938854089%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918715778&rft_id=info:pmid/28905287&rfr_iscdi=true